Symptom checker
Select audience type

Switch between content for healthcare professionals (PRO) and general audience (GEN).

ADD CONDITION

items per page

Mylanta Gas Minis Assorted Fruit Flavor

Last content change checked dailysee data sync status

Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2016
Label revision date
December 4, 2023
Drug Information (PDF)
Prescribing information, PDF file
Active ingredient
Dimethicone 125 mg
Other brand names
Dosage form
Tablet, Chewable
Route
Oral
Prescription status
OTC (over the counter)
CSA schedule
Not a scheduled drug
Pregnancy
See Pregnancy Use Section
Lactation
See Lactation Use Section
Marketed in the U.S.
Since 2016
Label revision date
December 4, 2023
Manufacturer
Infirst Healthcare Inc.
Registration number
M002
NDC root
62372-801
Drug Information (PDF)
Prescribing information, PDF file
Packaging Info (3 NDCs)
Packaging & NDC Codes (3)

If you are a healthcare professional or from the pharmaceutical industry please visit this version.

If you are a consumer or patient please visit this version.

Drug Overview

Mylanta GAS Minis are chewable mini-tablets designed to provide fast relief from the pressure, bloating, and discomfort associated with gas. This extra-strength formula is the #1 selling medicine for gas relief, making it a popular choice for those seeking quick and effective solutions. Available in great-tasting flavors like Arctic Mint and Cherry, these tablets come in a convenient on-the-go pack, making it easy for you to find relief whenever you need it.

Uses

If you're experiencing discomfort from gas, this medication can help relieve the pressure and bloating that often accompany it. You can expect fast relief from the uncomfortable sensations of gas, allowing you to feel more at ease.

Rest assured, this medication does not have any known teratogenic effects (which means it doesn't cause birth defects) or nonteratogenic effects. This makes it a safe option for those looking to alleviate gas-related discomfort.

Dosage and Administration

If you are an adult or a child aged 12 years and older, you can take this medication by thoroughly chewing 3 to 6 mini-tablets whenever you need them. It's important to remember not to exceed 12 mini-tablets in a 24-hour period unless your doctor has specifically advised you to do so. Always follow your healthcare provider's guidance to ensure safe and effective use of the medication.

What to Avoid

There are no specific contraindications, controlled substance classifications, or concerns regarding abuse, misuse, or dependence associated with this medication. Additionally, there are no explicit instructions indicating that you should not take or use this medication. Always consult with your healthcare provider for personalized advice and to ensure this medication is appropriate for you.

Side Effects

It's important to keep this medication out of the reach of children to prevent accidental ingestion. While specific side effects are not detailed here, always be aware of how you feel after taking any medication and report any unusual symptoms to your healthcare provider. If you have any concerns about potential side effects, don't hesitate to discuss them with your doctor.

Warnings and Precautions

It's important to keep this medication out of the reach of children to prevent accidental ingestion, which can be dangerous. Always store it in a safe place where children cannot access it.

If you have any concerns or experience unusual symptoms while using this medication, stop using it and call your doctor for guidance. Your health and safety are the top priority, so don’t hesitate to seek help if needed.

Overdose

If you suspect an overdose, it's important to stay calm and take immediate action. While there is no specific information available about the signs of overdose for this medication, general symptoms can include unusual drowsiness, confusion, or difficulty breathing. If you notice any of these signs, or if you are unsure, seek medical help right away.

In case of an overdose, contact your local emergency services or go to the nearest hospital. It's always better to be safe and get checked by a healthcare professional if you have any concerns about your health. Remember, timely intervention can make a significant difference.

Pregnancy Use

If you are pregnant or planning to become pregnant, it's important to know that there is no specific information available about the use of Mylanta Gas Minis (which contains simethicone) during pregnancy. This means that safety concerns, dosage adjustments, or any special precautions have not been clearly outlined.

Before using Mylanta Gas Minis or any medication while pregnant, it’s best to consult with your healthcare provider to discuss potential risks and ensure the safety of both you and your baby.

Lactation Use

If you are breastfeeding or planning to breastfeed, it's important to know that there is no specific information available regarding the use of this medication during nursing. This means that the effects on breast milk and your baby are not clearly defined.

As always, it's best to consult with your healthcare provider about any medications you are considering while breastfeeding. They can help you weigh the potential risks and benefits to ensure the safety of both you and your baby.

Pediatric Use

It's important to keep this medication out of the reach of children to ensure their safety. For adults and children aged 12 years and older, the recommended dosage is to thoroughly chew 3 to 6 mini-tablets as needed. However, you should not exceed 12 mini-tablets in a 24-hour period unless directed by a doctor. Always consult with a healthcare professional if you have any questions or concerns about using this medication for your child.

Geriatric Use

When it comes to using this medication in older adults, there is no specific information available about dosage adjustments, safety concerns, or special precautions. This means that if you or a loved one is an older adult, it’s important to consult with a healthcare provider before starting the medication. They can help determine the best approach based on individual health needs and any other medications being taken. Always prioritize open communication with your healthcare team to ensure safe and effective treatment.

Renal Impairment

It appears that there is no specific information regarding renal impairment (kidney problems) in the provided text. This means there are no dosage adjustments, special monitoring, or safety considerations outlined for patients with kidney issues. If you have concerns about how your kidney health may affect your treatment, it's important to discuss this with your healthcare provider, who can offer personalized guidance based on your individual situation.

Hepatic Impairment

If you have liver problems, it's important to know that there are no specific guidelines, dosage adjustments, or special monitoring instructions provided for your condition in the available information. This means that the medication may not have been studied in depth for its effects on individuals with liver impairment.

Always consult your healthcare provider for personalized advice and to discuss any concerns you may have regarding your liver health and medication use. They can help ensure that your treatment is safe and effective based on your individual health needs.

Drug Interactions

It's important to have open conversations with your healthcare provider about any medications you are taking, even if there are no known drug interactions or laboratory test interactions associated with them. This ensures that your treatment plan is safe and effective for your individual health needs.

Always keep your healthcare team informed about all the medications and supplements you use, as well as any lab tests you may undergo. This way, they can provide the best care tailored to you.

Storage and Handling

To ensure the best performance of your product, it's important to store it in a cool, dry place. Keep it protected from heat and moisture, as these can affect its quality. The ideal storage temperature is between 20-25°C (68-77°F).

When handling the product, make sure to do so with clean hands and in a clean environment to maintain its integrity. Following these guidelines will help you use the product safely and effectively.

Additional Information

For adults and children aged 12 years and older, you should thoroughly chew 3 to 6 mini-tablets as needed. However, it's important not to exceed 12 mini-tablets in a 24-hour period unless directed by a physician. Always follow your healthcare provider's advice regarding the use of this medication.

FAQ

What is Mylanta GAS Minis used for?

Mylanta GAS Minis are used to relieve pressure and bloating commonly referred to as gas, providing fast relief from discomfort.

How should I take Mylanta GAS Minis?

Adults and children 12 years and older should thoroughly chew 3-6 mini-tablets as needed, but do not exceed 12 mini-tablets in 24 hours unless advised by a physician.

What flavors are available for Mylanta GAS Minis?

Mylanta GAS Minis are available in great tasting Arctic Mint and Cherry flavors.

Are there any contraindications for using Mylanta GAS Minis?

No specific contraindications are listed for Mylanta GAS Minis in the provided information.

Is Mylanta GAS Minis safe to use during pregnancy?

The insert does not provide specific information regarding the use of Mylanta GAS Minis during pregnancy.

What should I do if the breakaway band on the container is broken or missing?

Do not use Mylanta GAS Minis if the breakaway band on the top of the container is broken or missing.

How should I store Mylanta GAS Minis?

Store Mylanta GAS Minis at 20-25° C (68-77° F) and protect them from heat and moisture.

What should I do if I have children at home?

Keep Mylanta GAS Minis out of the reach of children.

Packaging Info

Below are the non-prescription pack sizes of Mylanta Gas Minis Assorted Fruit Flavor (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mylanta Gas Minis Assorted Fruit Flavor.
Details

Drug Information (PDF)

This file contains official product information for Mylanta Gas Minis Assorted Fruit Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Description

Mylanta GAS Minis are chewable tablets formulated for the fast relief of bloating, pressure, and discomfort associated with gas. Each tablet is designed for extra strength and is available in assorted flavors, including Arctic Mint and Cherry. The product is packaged in a convenient on-the-go format, containing 50 tablets per unit. Mylanta is a registered trademark of McNeil Consumer Pharmaceuticals Co., and the product is manufactured for Infirst Healthcare Inc., located in Westport, CT. The formulation is currently under patent pending status. For complete labeling, it is advised to retain the outer packaging.

Uses and Indications

This drug is indicated for the relief of pressure and bloating commonly associated with gas. It provides fast relief from the discomfort, pressure, and bloating caused by gas accumulation in the gastrointestinal tract.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Adults and children aged 12 years and older are instructed to thoroughly chew 3 to 6 mini-tablets as needed. The total daily dosage should not exceed 12 mini-tablets within a 24-hour period, unless otherwise directed by a physician. It is essential that patients adhere to this guideline to ensure safe and effective use of the medication.

Contraindications

There are no contraindications listed for the use of this product. It is important to evaluate each patient's individual circumstances and medical history when considering treatment options.

Warnings and Precautions

It is imperative to keep this medication out of the reach of children to prevent accidental ingestion or misuse. Healthcare professionals should counsel patients and caregivers on the importance of proper storage and handling to ensure safety.

In addition, it is essential to monitor patients for any adverse reactions or side effects associated with the use of this medication. Regular follow-up appointments may be necessary to assess the patient's response to treatment and to make any necessary adjustments.

Healthcare providers are encouraged to educate patients about the signs and symptoms of potential complications, ensuring they understand when to seek immediate medical attention.

Side Effects

Patients should be advised to keep this medication out of the reach of children. This warning is critical to prevent accidental ingestion or misuse, which could lead to serious adverse reactions.

No specific adverse reactions have been reported in clinical trials or postmarketing experiences beyond the aforementioned warning. It is essential for healthcare providers to monitor patients for any unexpected effects and to report any adverse reactions that may arise during treatment.

Drug Interactions

There are no specific drug interactions identified for this medication. Additionally, no laboratory test interactions have been reported. Therefore, no dosage adjustments or monitoring recommendations are necessary based on drug or laboratory test interactions.

Packaging & NDC

Below are the non-prescription pack sizes of Mylanta Gas Minis Assorted Fruit Flavor (simethicone). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Packaging configurations for Mylanta Gas Minis Assorted Fruit Flavor.
Details

Pediatric Use

Pediatric patients should be kept out of the reach of children. For adolescents aged 12 years and older, the recommended dosage is to thoroughly chew 3-6 mini-tablets as needed. It is important not to exceed 12 mini-tablets in a 24-hour period unless advised and supervised by a physician.

Geriatric Use

Elderly patients may not have specific information regarding the use of this medication, including dosage adjustments, safety concerns, or special precautions. Therefore, healthcare providers should exercise caution when prescribing this medication to geriatric patients. It is advisable to monitor these patients closely for any adverse effects or changes in therapeutic response, given the lack of targeted data for this population.

Pregnancy

The safety of Mylanta Gas Minis (simethicone) during pregnancy has not been established, as the prescribing information does not provide specific data regarding its use in this population. Consequently, healthcare professionals should exercise caution when recommending this product to pregnant patients. There are no known safety concerns, dosage modifications, or special precautions outlined for the use of simethicone in pregnant women. As such, the potential risks and benefits should be carefully considered, and alternative treatments may be explored for managing gastrointestinal discomfort in this patient group. Women of childbearing potential should be advised to consult their healthcare provider before using Mylanta Gas Minis.

Lactation

There is no specific information available regarding the use of this medication in nursing mothers or any lactation considerations. Healthcare professionals should exercise caution and consider the potential risks and benefits when prescribing this medication to lactating mothers. The effects on breastfed infants have not been established, and further data may be necessary to inform clinical decisions.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of data does not preclude the need for careful evaluation and monitoring based on individual patient circumstances.

Overdosage

In the absence of specific information regarding overdosage, healthcare professionals are advised to exercise caution and adhere to general principles of management in cases of suspected overdose.

It is essential to monitor the patient closely for any potential symptoms that may arise from an overdose. Symptoms can vary widely depending on the substance involved and the individual patient's response.

In the event of an overdose, immediate medical attention should be sought. Healthcare providers should implement supportive care measures, which may include monitoring vital signs, providing symptomatic treatment, and ensuring the patient's safety.

If available, consultation with a poison control center or a medical toxicologist is recommended to guide further management and treatment options.

Documentation of the incident, including the substance involved, the amount taken, and the time of ingestion, is crucial for effective management and follow-up care.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data in these areas limits the understanding of the compound's potential effects in nonclinical settings.

Postmarketing Experience

No postmarketing experience details are provided in the insert.

Patient Counseling

Healthcare providers should advise patients to keep this medication out of the reach of children to prevent accidental ingestion or misuse. It is important to emphasize the potential risks associated with unauthorized access to the medication, highlighting the need for proper storage and safety measures.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It is essential to protect the product from heat and moisture to maintain its integrity. The recommended storage conditions are at a temperature range of 20-25° C (68-77° F). Proper handling and storage are crucial to ensure the product remains effective and safe for use.

Additional Clinical Information

Patients aged 12 years and older are advised to thoroughly chew 3-6 mini-tablets as needed, with a maximum limit of 12 mini-tablets within a 24-hour period unless directed otherwise by a physician. There is no additional information available regarding laboratory tests, abuse potential, patient counseling, or postmarketing experience.

Drug Information (PDF)

This file contains official product information for Mylanta Gas Minis Assorted Fruit Flavor, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)

Data Generation & Sources

This page was automatically generated and is maintained by the AllDrugs AI Data-Science Team. It was built from the FDA Structured Product Label (DailyMed) for Mylanta Gas Minis Assorted Fruit Flavor, retrieved by a validated AI data-extraction workflow.

All FDA-listed dosage forms and strengths are shown in the Packaging & NDC Codes section above. Regulatory status appears in the Summary Information panel above and was verified in the FDA National Drug Code directory and the NSDE NDC Directory daily file.

Note: an automated daemon monitors NSDE checksums; when the record for this NDC changes, the new file is pulled instantly and this page is refreshed.

No human clinician has reviewed this version.

Learn more in our Editorial Policy

Last AI update:

Primary FDA sources:

Orange Book data shown on this page are limited to Regulatory Status (Rx), Established Pharmacologic Class (EPC), and Mechanism of Action (MoA).

Regulatory data notice: Information on this page is reproduced verbatim from FDA public databases (NSDE, Orange Book, Purple Book, DailyMed SPL). NDA/ANDA drugs are FDA-approved, BLA biologics are FDA-licensed. Inclusion alone does not guarantee current market availability or imply FDA endorsement.

Medical disclaimer: This AI-generated content is provided for educational purposes only and does not constitute medical advice. Always consult a licensed healthcare professional for diagnosis or treatment decisions.